Evaluation of Clinical Efficacy of Extrammune Tablet in Recurrent Upper Respiratory Tract Infections (URTI)

Shweta A. Sutar

doi:10.21760/jaims.8.4.3

Shweta A. Sutar M.D. (Ayurved), Reg. No. I-6760-A, 103 &104, Bldg.no.3, Shivneri CHS, Dr. Annie Besant Road, Worli, Mumbai, Maharashtra, India.

DOI: https://doi.org/10.21760/jaims.8.4.3

Keywords: Immunity, Immune-Modulator, Upper Respiratory Tract Infection

Abstract

Aim of the study: The objective of this clinical study was to evaluate the efficacy of Extrammune Tablets, a polyherbal preparation in recurrent URTI patients. Materials and Methods: A clinical trial was conducted on 60 patients, including both the sexes, and from the age group 10-60 years having low immunity and who were constantly suffering from various upper respiratory tract infections. The study drug was administered as 2 tablet twice a day for 3 months. Evaluation Parameters: 1) Incidence of participant-reported number of Infections (URTI- influenza-like syndrome). 2) Duration and severity of episodes. 3) Number of new antibiotics prescription for infections. Results: There was a statistically significant improvement in all the parameters evaluated. Conclusion: The above clinical trial shows that Extrammune tablet can be used to boost the immune system to fight against various infections especially upper respiratory tract infections.

Downloads

Download data is not yet available.

References

Feld LG, Hyams JS. Respiratory Tract Infections in Children: New Developments in Diagnosis and Treatment. Consensus in Pediatrics. 2009; 1 (11): 1–46.

Cotton MF, Innes S, Jaspan H, Madide A, Rabie H. Management of upper respiratory tract infections in children. SA Fam Pract. 2008; 50 (2): 6–12.

NICE. Respiratory tract infections – antibiotic prescribing Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. National Institute of Health and Clinical Excellenece. 2008; 2008. p.1–122.

Simasek M, Blandino DA. Treatment of the common cold. Am Fam Physician. 2007; 75 (4): 515–20.

Arroll B. Common cold. Clinical Evidence. 2008; 06:1510.

Sharma U, Bala M, Kumar N, Singh B, Munshi RK, Bhalerao S. Immunomodulatory active compounds from Tinospora cordifolia. Journal of Ethnopharmacology. 2012;141(3):918-26.

Catanzaro M, Corsini E, Rosini M, Racchi M, Lanni C. Immunomodulators inspired by nature: a review on curcumin and echinacea. Molecules. 2018;23(11):2778.

Sawhney R, Berry V, Kumar A. Inhibitory Activity of Rubia cordifolia plant extract against ESBL producing Urinary E. coli isolates. Journal of Pharmacy Research. 2012;5(3):1328-30.

Son DJ, Akiba S, Hong JT, Yun YP, Hwang SY, Park YH, Lee SE. Piperine inhibits the activities of platelet cytosolic phospholipase A2 and thromboxane A2 synthase without affecting cyclooxygenase-1 activity: Different mechanisms of action are involved in the inhibition of platelet aggregation and macrophage inflammatory response. Nutrients. 2014;6(8):3336-52.

Vaibhav K, Shrivastava P, Javed H, Khan A, Ahmed ME, Tabassum R, Khan MM, Khuwaja G, Islam F, Siddiqui MS, Safhi MM, Islam F. Piperine suppresses cerebral ischemia-reperfusion-induced inflammation through the repression of COX-2, NOS-2, and NF-κB in middle cerebral artery occlusion rat model. Mol Cell Biochem. 2012;367(1-2):73-84.